Skip to main content

After 20 years and founder's sudden death, S.F. biotech wins 1st FDA drug approval

After 27 years and hundreds of millions of dollars, this San Francisco biotech pioneer plans to launch its first U.S. drug early next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.